Aiguo Shen

4.3k total citations
179 papers, 3.6k citations indexed

About

Aiguo Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Aiguo Shen has authored 179 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 40 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Aiguo Shen's work include Cancer-related Molecular Pathways (22 papers), Nerve injury and regeneration (19 papers) and Ubiquitin and proteasome pathways (18 papers). Aiguo Shen is often cited by papers focused on Cancer-related Molecular Pathways (22 papers), Nerve injury and regeneration (19 papers) and Ubiquitin and proteasome pathways (18 papers). Aiguo Shen collaborates with scholars based in China, United States and Australia. Aiguo Shen's co-authors include Chun Cheng, Yuchan Wang, Yueming Zhao, Linlin Sun, Yong Xu, Tao Tao, Yonghua Liu, Qi Chen, Song He and Mudan Lu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Aiguo Shen

175 papers receiving 3.5k citations

Peers

Countries citing papers authored by Aiguo Shen

Since Specialization

Citations

This map shows the geographic impact of Aiguo Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiguo Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiguo Shen more than expected).

Fields of papers citing papers by Aiguo Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiguo Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiguo Shen. The network helps show where Aiguo Shen may publish in the future.

Co-authorship network of co-authors of Aiguo Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Aiguo Shen. A scholar is included among the top collaborators of Aiguo Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiguo Shen. Aiguo Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GRWD1 inhibits nucleolar stress and reduces the sensitivity of hepatocellular carcinoma to oxaliplatin 2025 ·Genes & Diseases ·Yuanyuan Li, Yumeng Wu, (unknown), Wenjing Zhao, Jibin Liu, Yilang Wang, Xiubing Zhang, Jian Xu, Feng Sun, Dianzheng Zhang, Shudong Zhu, Aiguo Shen	0
2	Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma 2024 ·Scientific Reports ·(unknown), Cong Chen, Kang Chen, (unknown), Ning He, Xiubing Zhang, (unknown), Aiguo Shen, Suming Zhao	2
3	ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network 2023 ·Aging ·(unknown), Rui Ji, (unknown), (unknown), (unknown), Qichao Ni, (unknown), Yifan Chi, (unknown), Ying Miao, Minxin Shi, Xianghua Huang, Aiguo Shen	0
4	A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer 2023 ·Scientific Reports ·(unknown), (unknown), Lingling Shi, (unknown), (unknown), Xiaohui Jiang, (unknown), Zhijun Wu, Aiguo Shen	4
5	Pan‐Cancer Analysis Predicts the Immunological and Prognostic Role of ZC3H12C in KIRC 2022 ·BioMed Research International ·(unknown), Yumeng Wu, (unknown), Biao Wu, Xuming Wu, Jibin Liu, Lei Yang, Aiguo Shen	2
6	Development and Validation of a Novel Circadian Rhythm‐Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma 2022 ·BioMed Research International ·Yumeng Wu, Cheng Shen, Xinghui Wang, Wenjing Zhao, (unknown), (unknown), Yuanbin Chen, Jibin Liu, Xuming Wu, Aiguo Shen	4
7	Comprehensive Analysis of Glutamate‐Rich WD Repeat‐Containing Protein 1 and Its Potential Clinical Significance for Pancancer 2021 ·BioMed Research International ·Yumeng Wu, Xuming Wu, (unknown), Wenjing Zhao, (unknown), Biao Wu, Jibin Liu, (unknown), Aiguo Shen	6
8	An Integrative Pan‐Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors 2021 ·BioMed Research International ·Biao Wu, Yumeng Wu, (unknown), (unknown), Yuanyuan Li, (unknown), Yuanbin Chen, Wenjing Zhao, Jibin Liu, Xuming Wu, Aiguo Shen, Suqing Zhang	4
9	Research Progress of Nanozymes and Its Application in Analysis 2016 ·Chinese Journal of Applied Chemistry ·Junrong Li, Aiguo Shen, (unknown)	3
10	β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression 2016 ·Cancer Letters ·Chunhua Wan, Gong Chen, (unknown), Hua Lu, Xiaohong Li, (unknown), Yinji Chen, Xiaoling Ding, Song He, Wei Cao, Yingying Wang, (unknown), Ying Xiao, (unknown), Aiguo Shen	33
11	Overexpressed nuclear BAG‐1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin 2013 ·Journal of Cellular Biochemistry ·Wenkai Ni, Buyou Chen, (unknown), Cuihua Lu, Mingbing Xiao, (unknown), Yixing Zhang, Song He, Aiguo Shen, Runzhou Ni	19
12	β-1,4-Galactosyltransferase I involved in Schwann cells proliferation and apoptosis induced by tumor necrosis factor-alpha via the activation of MAP kinases signal pathways 2012 ·Molecular and Cellular Biochemistry ·(unknown), Huiguang Yang, Chun Cheng, (unknown), Xiujie Wu, (unknown), (unknown), (unknown), Yingying Wang, Yunhong Zhao, (unknown), Aiguo Shen	16
13	The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro. 2011 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Xi Qian, (unknown), Jing Meng, Cheng‐Yuan Peng, Aiguo Shen, Jun Chen	12
14	Combination of thiazolidinedione and hydralazine suppresses proliferation and induces apoptosis by PPARγ up-expression in MDA-MB-231 cells 2011 ·Experimental and Molecular Pathology ·Ying Jiang, Yeqing Huang, Chun Cheng, Weiqi Lu, Yixin Zhang, Xiaojuan Liu, Lin Zou, Qiwen Ben, Aiguo Shen	18
15	Expression of NLK and Its Potential Effect in Ovarian Cancer Chemotherapy 2011 ·International Journal of Gynecological Cancer ·Yuquan Zhang, Peng Chen, Gang Wu, You Wang, Rong Liu, Shuyun Yang, Song He, (unknown), Yuan Qin, Yeqing Huang, Aiguo Shen, (unknown)	26
16	Identification and potential role of PSD-95 in Schwann cells 2008 ·Neurological Sciences ·Aiguo Shen, Shangfeng Gao, (unknown), Haibo Wang, (unknown), Tao Tao, Shuqiong Niu, Xin Li, Chun Cheng	8
17	Peripheral Nerve Lesion Induces an Up-regulation of Spy1 in Rat Spinal Cord 2008 ·Cellular and Molecular Neurobiology ·Ye Huang, Yonghua Liu, Ying Chen, Xiaowei Yu, Junling Yang, Mudan Lu, (unknown), Qing Ke, Aiguo Shen, Meijuan Yan	9
18	Down-regulation of β1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells 2006 ·Glycobiology ·Jianhai Jiang, Jia-Lin Shen, Tao Wu, Yuanyan Wei, Xiaoning Chen, Hongliang Zong, Si Zhang, Maoyun Sun, Jianhui Xie, Xiangfei Kong, Yanzhong Yang, Aiguo Shen, Hanzhou Wang, Jianxin Gu	19
19	Study on Adsorbtion of 5-Fluorouracil Derivatives Containing Amino Acid Schiff Base on Silver Sol 2005 ·Journal of Analytical Science ·Min Ruan, Yong Ye, (unknown), (unknown), Aiguo Shen, (unknown)	1
20	Developmental regulation of β‐1,3‐galactosyltransferase‐1 gene expression in mouse brain 2003 ·FEBS Letters ·Dan Zhu, Aiguo Shen, Ying Wang, Xiaosong Gu, Jianxin Gu	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact